Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients
GermanyStudy of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
GermanyComparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease
GermanyStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
GermanyLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
GermanyStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
GermanyStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GermanyStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
GermanyStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
